Disc Medicine (IRON) Shares Outstanding (2020 - 2026)
Disc Medicine (IRON) posted quarterly Shares Outstanding (Entity) of $38.4 million for Q2 2026, up 10.66% year-over-year from $34.7 million in Q2 2025, and up 0.53% quarter-over-quarter from $38.2 million in Q1 2026.
Disc Medicine (IRON) Shares Outstanding (2020 - 2026) Analysis & Trends
Disc Medicine (IRON) has reported Shares Outstanding (Entity) for 7 consecutive years, with $38.4 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Shares Outstanding (Entity) rose 10.66% year-over-year to $38.4 million; the TTM figure through Jun 2026 stood at $38.4 million (up 10.66% YoY), while the FY2025 annual figure was $37.9 million, up 26.87% from the prior year.
- Shares Outstanding (Entity) advanced to $38.4 million in Q2 2026 per IRON's latest filing, from $38.2 million in the prior quarter.
- Across five years, Shares Outstanding (Entity) topped out at $38.4 million in Q2 2026 and bottomed at $1.0 million in Q4 2022.
- Historically, Shares Outstanding (Entity) has averaged $24.3 million across 5 years, with a median of $27.2 million in 2024.
- Annual changes were most pronounced in 2022 — Shares Outstanding (Entity) sank 75.94% — and 2023, when it soared 2243.48%.
- Disc Medicine's Shares Outstanding (Entity) stood at $1.0 million in 2022, then jumped by 2243.48% to $24.4 million in 2023, then climbed by 22.6% to $29.9 million in 2024, then grew by 26.87% to $37.9 million in 2025, then rose by 1.33% to $38.4 million in 2026.
- Business Quant data shows IRON's Shares Outstanding (Entity) at $38.4 million in Q2 2026, $38.2 million in Q1 2026, and $37.9 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 253.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 62.19 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 210.89 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.45 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 25.05 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 445.06 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 133.61 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 217.35 Mn |
| 10 | Disc Medicine | 3.02 Bn | 3.02 Bn | - | 38.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 38.69 Mn |
| Mar 31, 2026 | 38.49 Mn |
| Dec 31, 2025 | 35.30 Mn |
| Sep 30, 2025 | 35.18 Mn |
| Jun 30, 2025 | 35.02 Mn |
| Mar 31, 2025 | 33.32 Mn |
| Dec 31, 2024 | 27.61 Mn |
| Sep 30, 2024 | 29.94 Mn |
| Jun 30, 2024 | 25.65 Mn |
| Mar 31, 2024 | 24.81 Mn |
| Dec 31, 2023 | 22.32 Mn |
| Sep 30, 2023 | 24.32 Mn |
| Jun 30, 2023 | 21.48 Mn |
| Mar 31, 2023 | 18.95 Mn |
| Dec 31, 2022 | 1.04 Mn |
| Sep 30, 2022 | 4.33 Mn |
| Jun 30, 2022 | 4.32 Mn |
| Mar 31, 2022 | 4.32 Mn |
| Dec 31, 2021 | 4.04 Mn |
| Sep 30, 2021 | 4.31 Mn |